scholarly article | Q13442814 |
comparative study | Q58901591 |
P50 | author | Nicholas P J Day | Q28033668 |
Vanaporn Wuthiekanun | Q28321762 | ||
Wirongrong Chierakul | Q28321766 | ||
Direk Limmathurotsakul | Q28321770 | ||
Ploenchan Chetchotisakd | Q41653531 | ||
Siriluck Anunnatsiri | Q41653621 | ||
Sharon Peacock | Q44172566 | ||
Narisara Chantratita | Q52730888 | ||
Janjira Thaipadungpanit | Q56133645 | ||
Wipada Chaowagul | Q114417982 | ||
Kriangsak Phimda | Q114433980 | ||
Piroon Mootsikapun | Q114433981 | ||
Seksan Chaisuksant | Q114433982 | ||
P2093 | author name string | Bandit Thinkhamrop | |
Wattanachai Susaengrat | |||
Chalongchai Toondee | |||
Jiraporn Pilaikul | |||
Sunchai Phiphitaporn | |||
Surasakdi Wongrattanacheewin | |||
P2860 | cites work | Genetic diversity and microevolution of Burkholderia pseudomallei in the environment | Q21144556 |
Melioidosis: epidemiology, pathophysiology, and management | Q24522461 | ||
Recurrent melioidosis in patients in northeast Thailand is frequently due to reinfection rather than relapse | Q24535314 | ||
Outcomes of patients with melioidosis treated with cotrimoxazole alone for eradication therapy | Q24602857 | ||
Increasing incidence of human melioidosis in Northeast Thailand | Q24605111 | ||
Consensus guidelines for dosing of amoxicillin-clavulanate in melioidosis | Q24630305 | ||
Dosing regimens of cotrimoxazole (trimethoprim-sulfamethoxazole) for melioidosis | Q24651516 | ||
Multilocus Sequence Typing and Evolutionary Relationships among the Causative Agents of Melioidosis and Glanders, Burkholderia pseudomallei and Burkholderia mallei | Q28202846 | ||
Trimethoprim/sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei | Q28249826 | ||
Burkholderia Pseudomallei is genetically diverse in agricultural land in Northeast Thailand | Q28475834 | ||
The epidemiology and clinical spectrum of melioidosis: 540 cases from the 20 year Darwin prospective study | Q33769912 | ||
A comparison of chloramphenicol, trimethoprim-sulfamethoxazole, and doxycycline with doxycycline alone as maintenance therapy for melioidosis | Q33873221 | ||
Maintenance therapy of melioidosis with ciprofloxacin plus azithromycin compared with cotrimoxazole plus doxycycline | Q33952994 | ||
Open-label randomized trial of oral trimethoprim-sulfamethoxazole, doxycycline, and chloramphenicol compared with trimethoprim-sulfamethoxazole and doxycycline for maintenance therapy of melioidosis | Q34077038 | ||
A prospective comparison of co-amoxiclav and the combination of chloramphenicol, doxycycline, and co-trimoxazole for the oral maintenance treatment of melioidosis | Q34371469 | ||
Risk factors for recurrent melioidosis in northeast Thailand | Q34567077 | ||
Activities of daily living associated with acquisition of melioidosis in northeast Thailand: a matched case-control study | Q34600705 | ||
GeoSentinel surveillance of illness in returned travelers, 2007-2011 | Q36239501 | ||
Simultaneous infection with more than one strain of Burkholderia pseudomallei is uncommon in human melioidosis | Q36314343 | ||
Workshop on treatment of and postexposure prophylaxis for Burkholderia pseudomallei and B. mallei Infection, 2010 | Q36570592 | ||
Melioidosis: acute and chronic disease, relapse and re-activation | Q38958161 | ||
The antimicrobial susceptibility of Pseudomonas pseudomallei. Emergence of resistance in vitro and during treatment | Q38961152 | ||
A comparison of antibiotic susceptibility testing methods for cotrimoxazole with Burkholderia pseudomallei. | Q39356268 | ||
The pros and cons of noninferiority trials | Q39361105 | ||
Non-inferiority trials: design concepts and issues - the encounters of academic consultants in statistics | Q57506046 | ||
Melioidosis | Q84964739 | ||
P433 | issue | 9919 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | antibiotic | Q12187 |
doxycycline | Q422442 | ||
sulfamethoxazole/trimethoprim | Q898623 | ||
melioidosis | Q963944 | ||
multicenter clinical trial | Q6934595 | ||
P304 | page(s) | 807-14 | |
P577 | publication date | 2014-03-01 | |
P1433 | published in | The Lancet | Q939416 |
P1476 | title | Trimethoprim-sulfamethoxazole versus trimethoprim-sulfamethoxazole plus doxycycline as oral eradicative treatment for melioidosis (MERTH): a multicentre, double-blind, non-inferiority, randomised controlled trial | |
P478 | volume | 383 |
Q50109311 | A case report of Tubo-ovarian abscess caused by Burkholderia pseudomallei |
Q57193551 | A case report of melioidosis complicated by infective sacroiliitis in Sri Lanka |
Q53679268 | A man with unsuspected marine eosinophilic gastritis. |
Q40542863 | Antibiotic resistance in Burkholderia species |
Q61803231 | Clinical Manifestations, Antimicrobial Drug Susceptibility Patterns, and Outcomes in Melioidosis Cases, India |
Q38598756 | Clinical Outcomes in Musculoskeletal Involvement of Burkholderia Pseudomallei Infection |
Q39263011 | Correlation between biofilm production, antibiotic susceptibility and exopolysaccharide composition in Burkholderia pseudomallei bpsI, ppk, and rpoS mutant strains |
Q90817977 | Cranial Melioidosis Presenting as Osteomyelitis and/or Extra-Axial Abscess: Literature Review |
Q35015687 | Cutaneous melioidosis in a healthy Danish man after travelling to South-East Asia |
Q33843665 | Demonstrating the Protective Efficacy of the Novel Fluoroquinolone Finafloxacin against an Inhalational Exposure to Burkholderia pseudomallei |
Q58695264 | Factors affecting clinical outcomes in the management of melioidosis in Singapore: a 16-year case series |
Q58761277 | Feasibility and initial outcomes of a multifaceted prevention programme of melioidosis in diabetic patients in Ubon Ratchathani, northeast Thailand |
Q35116418 | Functional characterization and evaluation of in vitro protective efficacy of murine monoclonal antibodies BURK24 and BURK37 against Burkholderia pseudomallei |
Q36361693 | Hematopoietic lineage skewing and intestinal epithelia degeneration in aged mice with telomerase RNA component deletion |
Q90243749 | Human Melioidosis |
Q35219793 | Intravenous therapy duration and outcomes in melioidosis: a new treatment paradigm |
Q36958444 | Investigation of Recurrent Melioidosis in Lao People's Democratic Republic by Multilocus Sequence Typing. |
Q39582866 | Loss of Methyltransferase Function and Increased Efflux Activity Leads to Doxycycline Resistance in Burkholderia pseudomallei |
Q57094969 | Melioidosis |
Q61699558 | Melioidosis |
Q43126480 | Melioidosis diagnostic workshop, 2013. |
Q57147972 | Melioidosis in Brunei Darussalam |
Q64239581 | Melioidosis with a subdural collection - a case report |
Q64238619 | Melioidosis, an emerging infectious disease in the Midwest Brazil: A case report |
Q33663333 | Melioidosis: Clinical impact and public health threat in the tropics. |
Q64095025 | Melioidosis: The hazards of incomplete peer-review |
Q33816438 | New insights from the 7th World Melioidosis Congress 2013. |
Q97566851 | Prolonged intermittent fever and massive splenomegaly in a miner working in the tropical jungle, China |
Q38690224 | Pulmonary melioidosis presenting with pleural effusion: A case report and review of literature |
Q39307381 | Splenic abscesses in a returning traveler |
Q90232462 | Successful Treatments and Management of A Case of Canine Melioidosis |
Q39446204 | Susceptibility of Clinical Isolates of Burkholderia pseudomallei to a Lipid A Biosynthesis Inhibitor |
Q38330997 | The expanding role of co-trimoxazole in developing countries |
Q34538191 | Treatment and prophylaxis of melioidosis |
Q47876732 | Treatment of diseases acquired abroad |
Q42942530 | Trimethoprim/sulfamethoxazole resistance in Burkholderia pseudomallei. |
Q42534233 | Trimethoprim/sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei from Thailand |
Q37685353 | Two fatal cases of melioidosis on the Thai-Myanmar border |
Search more.